Shell Point Retirement Community continues its fifth annual 2020 Medical Breakthroughs & Discoveries series on Feb. 4 with a presentation by Julie A. Johnson, Pharm.D., dean and distinguished professor at the University of Florida College of Pharmacy.
Free and open to the public, the presentation, entitled “What Is It and How It Can Improve Healthcare,” will discuss the latest advances in medicine, considering individual factors, especially genetics, in making decisions about a person’s health care. Johnson will address these advances especially as they relate to helping select the right medications for individuals based on their genetics.
The program will be held at 7 p.m. on Tuesday, Feb. 4 in the Village Church Auditorium on The Island at Shell Point, 15100 Shell Point Blvd. in Fort Myers. Registration is requested by calling 239-433-7936.
In addition to serving as dean of the University of Florida College of Pharmacy, Johnson is also a distinguished professor of pharmacy and medicine. She received her bachelor’s degree in pharmacy from Ohio State University and her Pharm.D. from the University of Texas at Austin and the UT Health Science Center in San Antonio, Texas. She completed a post-doctoral fellowship in cardiovascular pharmacology and pharmacokinetics from Ohio State University.
Johnson’s research focuses on cardiovascular pharmacogenomics and genomic medicine implementation. She is an internationally recognized leader in pharmacogenomics and genomic medicine, with more than 290 peer-reviewed publications and nearly $45 million in research funding as principal investigator. In 2015, 2016 and 2017, she was named as a Thomson Reuters Highly Cited Scientist in Pharmacology and Toxicology, and in the Cross Discipline category in 2018, indicating that Johnson is in the top 1% of the most highly cited scientists in the field globally.
Johnson has served on the Nonprescription Drugs Advisory Committee of the FDA, the XNDA Study Section at National Institutes of Health (NIH), and in numerous scientific capacities with NIH’s National Heart, Lung and Blood Institute. She has held leadership roles in the American College of Clinical Pharmacy, the American Heart Association and the American Society of Clinical Pharmacology and Therapeutics, for which she completed her term as president in 2017.
Shell Point’s 2020 Medical Breakthroughs & Discoveries is a community speaker series designed to share updates on the latest advances in medical research and health care practice.
About Shell Point Retirement Community
Shell Point Retirement Community, founded in 1968, is a nonprofit continuing care retirement community located in Fort Myers, Florida. Shell Point offers independent retirement living, assisted living, and skilled nursing for its 2,500 residents in an active, resort-style environment. Lifestyle amenities include deep-water boating access with free dockage, a championship 18-hole golf course, and other recreational and educational activities. To learn more, visit www.shellpoint.org or call 1-800-780-1131.